Ce Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 14
- Cell death mechanisms and regulation 5
- Oncology 36
- Cancer Immunotherapy and Biomarkers 17
- Pancreatic and Hepatic Oncology Research 8
- Co-authors
- Xiujuan Qu (47 shared papers)Xiaofang Che (41 shared papers)Yunpeng Liu (32 shared papers)Yibo Fan (27 shared papers)Kezuo Hou (31 shared papers)Ling Xu (20 shared papers)Ti Wen (12 shared papers)Zhi Li (14 shared papers)
- Journals
- Frontiers in Oncology (7 papers)BMC Cancer (6 papers)Cell Biology International (4 papers)Frontiers in Immunology (4 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Ce Li
68 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 758
- Oncology 624
- Molecular Biology 1.1k
- Immunology 310
- Pulmonary and Respiratory Medicine 201
Countries citing papers authored by Ce Li
This map shows the geographic impact of Ce Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ce Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ce Li more than expected).
Fields of papers citing papers by Ce Li
This network shows the impact of papers produced by Ce Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ce Li. The network helps show where Ce Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ce Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 151 | |
| 2 | 2016 | 112 | |
| 3 | 2018 | 73 | |
| 4 | 2014 | 72 | |
| 5 | 2014 | 58 | |
| 6 | 2018 | 56 | |
| 7 | 2020 | 52 | |
| 8 | 2018 | 52 | |
| 9 | 2018 | 50 | |
| 10 | 2015 | 47 | |
| 11 | 2017 | 46 | |
| 12 | 2020 | 46 | |
| 13 | 2021 | 41 | |
| 14 | 2017 | 36 | |
| 15 | 2014 | 34 | |
| 16 | 2020 | 34 | |
| 17 | 2017 | 34 | |
| 18 | 2021 | 32 | |
| 19 | 2020 | 30 | |
| 20 | 2015 | 28 |
About Ce Li
Ce Li is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 70 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (10 papers), Pancreatic and Hepatic Oncology Research (8 papers), Cancer, Lipids, and Metabolism (5 papers), Immune Cell Function and Interaction (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Cancer Research (758 citations), Oncology (624 citations), Molecular Biology (1.1k citations), Immunology (310 citations) and Pulmonary and Respiratory Medicine (201 citations). Ce Li has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Xiujuan Qu, Xiaofang Che, Yunpeng Liu, Yibo Fan, Kezuo Hou, Ling Xu, Ti Wen, Zhi Li, Shuo Wang and Yunpeng Liu. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Cell Biology International, Frontiers in Immunology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.